SearchDictionaryMobileLogin Register FREE

3-methoxytyramine (methoxytyramine)

27  relevant articles (1 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd

Also Known As:
methoxytyramine; 3-methoxytyramine hydrochloride

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pacak, Karel: 1 article (04/2005)
2. Adams, Karen T: 1 article (04/2005)
3. Lai, Edwin W: 1 article (04/2005)
4. Brouwers, Frederieke M: 1 article (04/2005)
5. Sullivan, Patricia: 1 article (04/2005)
6. Csako, Gyorgy: 1 article (04/2005)
7. Eisenhofer, Graeme: 1 article (04/2005)
8. Goldstein, David S: 1 article (04/2005)

Related Diseases

1. Tachycardia (Tachyarrhythmias)
2. Asphyxia (Suffocation)
3. Ischemia
01/01/1989 - "Dialysate serotonin and 3-methoxytyramine concentrations were below detection limits except for samples collected during ischemia and early reperfusion."
04/01/1995 - "L-Arginine but not D-arginine increased the striatal content of dopamine in pre- and postischemia whereas it lowered the levels of dopamine and 3-methoxytyramine induced by ischemia"
01/01/1992 - "A 15 min period of bilateral transient incomplete ischemia (ICI) was induced, and the concentrations of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), 3-methoxytyramine (3-MT), and homovanillic acid (HVA) were measured in the striatum by means of HPLC and electrochemical detection at the end of ischemia without reperfusion, and after 1 h, 24 h, 72 h, 144 h, and 288 h of postischemic cerebral reperfusion"
12/01/1990 - "With regard to the metabolites of the monoamines, the changes during and after reperfusion were almost similar in all regions: O-methylated metabolites, normetanephrine and 3-methoxytyramine, markedly increased during ischemia; After reperfusion, the elevated levels of normetanephrine and 3-methoxytyramine returned to normal, while deaminated metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid, homovanillic acid (HVA), and 3-methoxy-4-hydroxy-phenylethyleneglycol clearly increased"
03/01/1990 - "During ischemia, extracellular dopamine increased dramatically (156 times baseline), as did 3-methoxytyramine (3-MT), whereas 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) decreased (15-25% of baseline)"
Get all the results and reference details, order at left...
4. Neoplasms (Cancer)
5. Anoxia (Hypoxia)
22 Diseases and 27 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1. Dopamine (Intropin)
2. 3,4-Dihydroxyphenylacetic Acid
3. Dihydroxyphenylalanine (Dopa)
4. Homovanillic Acid
5. Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
6. Normetanephrine
7. Metanephrine
8. Serotonin (5 Hydroxytryptamine)
9. Norepinephrine (Noradrenaline)
10. phenylacetic acid (phenylacetate)
31 Drugs and Important Bio-Agents and 26 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Searches
  • 2 clicks from Disease to Drug to Evidence
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • Request Institution License details >>
Price:$490.00 access via web interface, 1 year subscription
Proceed to Checkout >>
Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m", 1 year subscription
Proceed to Checkout >>